During the past decade, UMC Utrecht, Dept. of Internal Medicine, MDL conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UMC Utrecht, Dept. of Internal Medicine, MDL" are "Ulcerative Colitis" (2 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "UMC Utrecht, Dept. of Internal Medicine, MDL" in a lesser frequency.

Most popular intervention types in "UMC Utrecht, Dept. of Internal Medicine, MDL" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (1 trials), "Mirikizumab" (1 trials), "Mirikizumab IV" (1 trials), "Mirikizumab SC" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "UMC Utrecht, Dept. of Internal Medicine, MDL" are 3 trials for "All" genders.

Currently, there are NaN active trials in "UMC Utrecht, Dept. of Internal Medicine, MDL". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UMC Utrecht, Dept. of Internal Medicine, MDL, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UMC Utrecht, Dept. of Internal Medicine, MDL, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".